Pharmacokinetic variability and exposures of fluconazole, anidulafungin, and caspofungin in intensive care unit patients: Data from multinational Defining Antibiotic Levels in Intensive care unit (DALI) patients Study.

May 14, 2015 at 8:19 am

Crit Care. 2015 Feb 4;19(1):33.

Sinnollareddy MG1,2,3, Roberts JA4,5, Lipman J6,7, Akova M8, Bassetti M9, De Waele JJ10, Kaukonen KM11, Koulenti D12,13, Martin C14,15, Montravers P16, Rello J17, Rhodes A18, Starr T19, Wallis SC20, Dimopoulos G21; DALI Study authors.

1Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. mahi716@yahoo.com.

2School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, Australia. mahi716@yahoo.com.

3Therapeutics Research Centre, Basil Hetzel Institute for Translational Health Research, The Queen Elizabeth Hospital, Adelaide, Australia. mahi716@yahoo.com.

4Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. j.roberts2@uq.edu.au.

5Royal Brisbane and Women’s Hospital, Brisbane, Australia. j.roberts2@uq.edu.au.

6Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. j.lipman@uq.edu.au.

7Royal Brisbane and Women’s Hospital, Brisbane, Australia. j.lipman@uq.edu.au.

8School of Medicine, Hacettepe University, Ankara, Turkey. makova@hacettepe.edu.tr.

9Azienda Ospedaliera Universitaria Santa Maria della Misericordia, Udine, Italy. mattba@tin.it.

10Ghent University Hospital, Ghent, Belgium. Jan.DeWaele@UGent.be.

11Helsinki University Central Hospital, Helsinki, Finland. maija.kaukonen@monash.edu.

12Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. deskogr@yahoo.gr.

13Attikon University Hospital, Athens, Greece. deskogr@yahoo.gr.

14Hospital Nord, Marseille, France. claude.martin@mail.ap-hm.fr.

15AzuRea Group, Antibes, France. claude.martin@mail.ap-hm.fr.

16Centre Hospitalier Universitaire Bichat-Claude Bernard, AP-HP, Université Paris VII, Paris, France. philippe.montravers@bch.ap-hop-paris.fr.

17CIBERES, Vall d’Hebron Institute of Research, Universitat Autonoma de Barcelona, Barcelona, Spain. jrello@crips.es.

18St George’s Healthcare NHS Trust and St George’s University of London, London, England. andrewrhodes@nhs.net.

19Royal Brisbane and Women’s Hospital, Brisbane, Australia. Therese.starr@health.qld.gov.au.

20Burns Trauma and Critical Care Research Centre, The University of Queensland, Brisbane, Australia. s.wallis@uq.edu.au.

21Attikon University Hospital, Athens, Greece. gdimop@med.uoa.gr.

PDF

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4335513/pdf/13054_2015_Article_758.pdf

Entry filed under: Antimicoticos, Infecciones micoticas. Tags: .

Population pharmacokinetic analysis of voriconazole and anidulafungin in adult patients with invasive aspergillosis. Diagnosis and management of urinary tract infection in older adults.


Calendar

May 2015
M T W T F S S
« Apr   Jun »
 123
45678910
11121314151617
18192021222324
25262728293031

Most Recent Posts


%d bloggers like this: